Israel Active

Israel’s Novocure (see previously) announced that using its TTFields (Tumor Treating electrical Fields) technology in combination with other therapies, improved overall patient survival compared to standard therapies alone.

Israel’s Purple Biotech has two promising treatments for solid tumors in clinical (human) trials. CM24 has completed Phase 1 and is in Phase 2 for Pancreatic cancer. NT219 is in Phase 1/2 in the USA. Purple is also partnering Mor, the technology transfer subsidiary of Israel’s Clalit.

Very positive video featuring the groundbreaking cancer treatment of Israel’s New Phase (see previously). 12 patients at Israel’s Beilinson (Rabin) Medical Center in Petah Tikva are undergoing Phase 1 human safety and tolerance trials.

The new Israeli-developed Microclimate Suit is successfully eliminating congestion in heart failure patients at Israel’s Rambam hospital. It evaporates body fluids, alleviating symptoms of heart failure by reducing the level of the stress hormone BNP (B-type natriuretic peptide) by up to 50%.

Israeli doctors regularly treat eye diseases in Africa (see and previously). Sheba Medical Center has now launched a humanitarian mission to Ilorin, Nigeria to treat eye-cancer in children and improve long-term quality optical care, by establishing an intra-arterial chemotherapy center.

Nine Israeli startups have been selected for Google for Startups’ first Growth Academy program for startups in the fields of medicine and quality of life. They are Olive Diagnostics, Kai, Emble, Droxi, BoBo Balance, Agado Live, AIVF, X-Trodes, and Ritual Health Technologies.

IsraelActive.com (see ) contains over a dozen articles describing how Israeli medical clowns help hospital patients. Now Tel Aviv University researchers have documented 40 different skills that the clowns deploy to enable patients to overcome crises and move towards healing.

When a nine-year-old Israeli girl lost a tooth, she accidentally sucked it into her lung, blocking her airway – a medical and life-threatening emergency. Doctors at Haifa’s Rambam Pediatric Emergency Trauma Unit became “tooth fairies” and used a guided camera to pull the tooth from her lung.

Three years ago, one of a group of Israeli cyclists died when he had a heart attack, miles from the nearest hospital. Since then, the group carries a portable defibrillator on all trips. It recently saved the life of another member of the group, who suffered cardiac arrest in the Negev desert.

Since its first trial in 2019, Israel’s Active Implants (see previously) has performed nearly 1,000 implants of its NUsurface synthetic meniscus in Israel and Europe. It expects FDA approval to allow launch in the US in 2024.